Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

Advanced biliary tract carcinomas (BTCs) are often diagnosed at an advanced/metastatic stage and have a poor prognosis. The combination of gemcitabine and oxaliplatin (GEMOX) has shown promising activity in this setting. This international phase II study evaluated the efficacy and safety of GEMOX as...

Descripción completa

Detalles Bibliográficos
Autores principales: André, T, Reyes-Vidal, J M, Fartoux, L, Ross, P, Leslie, M, Rosmorduc, O, Clemens, M R, Louvet, C, Perez, N, Mehmud, F, Scheithauer, W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538748/
https://www.ncbi.nlm.nih.gov/pubmed/19238628
http://dx.doi.org/10.1038/sj.bjc.6604628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538748/
https://www.ncbi.nlm.nih.gov/pubmed/19238628
http://dx.doi.org/10.1038/sj.bjc.6604628

Ejemplares similares